Cover Image

Multispecific anti-HIV duoCAR-T cell therapy mediates robust HIV suppression and elimination of HIV-infected cells in humanised mice

Saved in:

Bibliographic Details
Main Authors:	K. Anthony-Gonda (Author), A. Bardhi (Author), A. Ray (Author), W. Krueger (Author), D. Schneider (Author), Z. Zhu (Author), R. Orentas (Author), D. Dimitrov (Author), H. Goldstein (Author), B. Dropulic (Author)
Format:	Book
Published:	Elsevier, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the in vivo capacity of broadly neutralising anti-HIV antibodies to eliminate latently infected cells from HIV-infected individuals using a novel humanised mouse model
by: N. Flerin, et al.
Published: (2017)

Improved HIV-1 clearance with BIT225 in the HIV-1 infected humanised mouse model
by: J. Wilkinson, et al.
Published: (2017)

O4 Spatial distribution of HIV in antiretroviral-treated humanised mice
by: Virginie Fievez, et al.
Published: (2016)

μ-Lat: a high-throughput humanised mouse model of latent HIV infection
by: H. Sperber, et al.
Published: (2019)

26 Towards an HIV functional cure with CAR-T cells: elucidating mechanisms underlying the extremely high potency of bispecific anti-HIV CARs designed for optimal activity and minimal immunogenicity
by: M.H. Ghanem, et al.
Published: (2017)

Developability considerations for bispecific and multispecific antibodies
by: Alaa Amash, et al.
Published: (2024)

PP 6.2 - 00106 CAR/CXCR5 T cells contact HIV vRNA+ cells in HIV-infected humanized DRAGA mice
by: P. Pumtang-On, et al.
Published: (2022)

"Stapling" scFv for multispecific biotherapeutics of superior properties
by: Lauren E. Boucher, et al.
Published: (2023)

HUMANISED ONCOLOGICAL NURSE CARE
by: Paulo Alexandre Oliveira Marques, et al.
Published: (2024)

In situ multiplex RNA fluorescence imaging of SHIV1157ipd3N4 and anti-HIV CAR T cells to study CAR T cell trafficking to sites of viral reservoir in macaque lymphoid tissues
by: K. Eichholz, et al.
Published: (2017)

Alemtuzumab-induced elimination of HIV-1-infected immune cells
by: Kiat Ruxrungtham, et al.
Published: (2016)

Uncovering mechanisms of HIV persistence in HIV controllers by HIV sequence analysis in CD4 T cell subsets
by: E. Boritz, et al.
Published: (2015)

HIV antibody and T cell responses on ART are associated with HIV DNA but not RNA
by: S.M. Keating, et al.
Published: (2017)

Elimination of HIV-1/SHIV infected cells by combinations of bispecific HIV x CD3 DART® molecules
by: M. Tuyishime, et al.
Published: (2019)

HIV/AIDS Risk for Young Female Petty Traders at Car Parks
by: Yahya Muhammed Bah
Published: (2017)

Something is moving in hospitals, could it be clinical humanisation?
by: Antonia Pades Jiménez, et al.
Published: (2012)

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells
by: Blair B. Madison, et al.
Published: (2022)

Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics
by: Florian Heinkel, et al.
Published: (2022)

Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells
by: Amanda B. Buckingham, et al.
Published: (2024)

Development of a robust cell-based high-throughput screening assay to identify targets of HIV-1 viral protein R dimerization
by: Zych C, et al.
Published: (2013)

Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression
by: Akram Tayanloo-Beik, et al.
Published: (2024)

Stable Transcriptional Repression and Parasitism of HIV-1
by: Surya Shrivastava, et al.
Published: (2018)

The social construction of HIV/AIDS
by: Natalie Goldstein, et al.
Published: (2003)

Modulation of Multispecific Transporters by <i>Uncaria tomentosa</i> Extract and Its Major Phytoconstituents
by: Nóra Szilvásy, et al.
Published: (2024)

Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
by: Ágnes Telbisz, et al.
Published: (2021)

HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies
by: Francesca Chiodi
Published: (2018)

Correction: Use of Humanised Rat Basophilic Leukaemia Cell Line RS-ATL8 for the Assessment of Allergenicity of Proteins.
Published: (2014)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015)

Efforts to eliminate the latent reservoir in resting CD4+ T cells: strategies for curing HIV-1 infection
by: Ya-Chi Ho, et al.
Published: (2015)

Trends in undiagnosed HIV prevalence in England and implications for eliminating HIV transmission by 2030: an evidence synthesis model
by: Anne M Presanis, PhD, et al.
Published: (2021)

Engineering CAR-T cells
by: Cheng Zhang, et al.
Published: (2017)

Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.
by: Daniel Wan, et al.
Published: (2014)

Defining the landscape of HIV-specific T-cell responses in HIV-1 infected durably suppressed participants
by: J. Warren, et al.
Published: (2017)

Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies
by: J.L. Nordstrom, et al.
Published: (2015)

Donor T cells for CAR T cell therapy
by: Tiffany C. Y. Tang, et al.
Published: (2022)

Regulatory T cells: the ultimate HIV reservoir?
by: Joseph Rocco, et al.
Published: (2018)

Limitations of employing antibody drug conjugates (ADCs) for targeting HIV infected cells as a strategy for hiv cure
by: J. Strizki, et al.
Published: (2015)

In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir
by: R. Fromentin, et al.
Published: (2017)

Case report: Robust response of metastatic clear cell sarcoma treated with cabozantinib and immunotherapy
by: Rakefet Sidlik Muskatel, et al.
Published: (2022)

Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapy
by: J. Stern, et al.
Published: (2019)